780TiPPhase II trial of perioperative PD-L1 inhibition with avelumab and mDCF chemotherapy for resectable locally advanced gastric and esophago-gastric adenocarcinoma. (23rd October 2018) - Alcindor, T; Awan, A; Opu, T; Asselah, J; Vanhuyse, M; Mueller, C; Ferri, L